SOGULASVHILI, T. et al. Colchicine Plus Rosuvastatin/Ezetimibe for Residual Cardiovascular Risk: Mechanistic Rationale, Safety Concerns and Research Priorities. Georgian Biomedical and Medical Nexus, v. 4, n. 3, p. 177–186, 24 Jul.2026.